Great work @marcus-ruscetti.bsky.social
Our study contributes a more generalizable approach to stabilize STING and increase immunogenicity in cold tumors where STING expression is silenced through targeting PPT1. We believe this could open the door for rationale combinations with STING agonists and ICB therapies.